BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 33992091)

  • 21. Promoter methylation status of DNA repair gene (hMLH1) in gastric carcinoma patients of the Kashmir valley.
    Wani M; Afroze D; Makhdoomi M; Hamid I; Wani B; Bhat G; Wani R; Wani K
    Asian Pac J Cancer Prev; 2012; 13(8):4177-81. PubMed ID: 23098428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methylation of a panel of genes in peripheral blood leukocytes is associated with colorectal cancer.
    Luo X; Huang R; Sun H; Liu Y; Bi H; Li J; Yu H; Sun J; Lin S; Cui B; Zhao Y
    Sci Rep; 2016 Jul; 6():29922. PubMed ID: 27453436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetic Silencing of the MLH1 Promoter in Relation to the Development of Gastric Cancer and its use as a Biomarker for Patients with Microsatellite Instability: a Systematic Analysis.
    Hu G; Qin L; Zhang X; Ye G; Huang T
    Cell Physiol Biochem; 2018; 45(1):148-162. PubMed ID: 29334683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA Methylation in Peripheral Blood and Risk of Gastric Cancer: A Prospective Nested Case-control Study.
    Chamberlain JA; Dugué PA; Bassett JK; Milne RL; Joo JE; Wong EM; Brinkman MT; Stuart GW; Boussioutas A; Southey MC; Giles GG; Mitchell H; English DR; Hodge AM
    Cancer Prev Res (Phila); 2021 Feb; 14(2):233-240. PubMed ID: 32958588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced Kiss‑1 expression is associated with clinical aggressive feature of gastric cancer patients and promotes migration and invasion in gastric cancer cells.
    Li C; Yuan L; Han S; Xuan M; Liu D; Tian B; Yu W
    Oncol Rep; 2020 Sep; 44(3):1149-1157. PubMed ID: 32705229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Zic1 Promoter Hypermethylation in Plasma DNA Is a Potential Biomarker for Gastric Cancer and Intraepithelial Neoplasia.
    Chen X; Lin Z; Xue M; Si J; Chen S
    PLoS One; 2015; 10(7):e0133906. PubMed ID: 26207911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PBX3 hypermethylation in peripheral blood leukocytes predicts better prognosis in colorectal cancer: A propensity score analysis.
    Sun H; Huang H; Li D; Zhang L; Zhang Y; Xu J; Liu Y; Liu Y; Zhao Y
    Cancer Med; 2019 Jul; 8(8):4001-4011. PubMed ID: 31140752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The status of WIF1 methylation in cell-free DNA is associated with the insusceptibility for gefitinib in the treatment of lung cancer.
    Shen Z; Chen C; Sun J; Huang J; Liu S
    J Cancer Res Clin Oncol; 2021 Aug; 147(8):2239-2248. PubMed ID: 34037837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The value of serum RASSF10 hypermethylation as a diagnostic and prognostic tool for gastric cancer.
    Xue WJ; Feng Y; Wang F; Li P; Liu YF; Guo YB; Wang ZW; Mao QS
    Tumour Biol; 2016 Aug; 37(8):11249-57. PubMed ID: 26945573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic relevance of Wnt-inhibitory factor-1 (WIF1) and Dickkopf-3 (DKK3) promoter methylation in human breast cancer.
    Veeck J; Wild PJ; Fuchs T; Schüffler PJ; Hartmann A; Knüchel R; Dahl E
    BMC Cancer; 2009 Jul; 9():217. PubMed ID: 19570204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ONECUT2 upregulation is associated with CpG hypomethylation at promoter-proximal DNA in gastric cancer and triggers ACSL5.
    Seo EH; Kim HJ; Kim JH; Lim B; Park JL; Kim SY; Lee SI; Jeong HY; Song KS; Kim YS
    Int J Cancer; 2020 Jun; 146(12):3354-3368. PubMed ID: 32129880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin-like growth factor 2 hypomethylation of blood leukocyte DNA is associated with gastric cancer risk.
    Yuasa Y; Nagasaki H; Oze I; Akiyama Y; Yoshida S; Shitara K; Ito S; Hosono S; Watanabe M; Ito H; Tanaka H; Kang D; Pan KF; You WC; Matsuo K
    Int J Cancer; 2012 Dec; 131(11):2596-603. PubMed ID: 22447362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer.
    Pei L; He X; Li S; Sun R; Xiang Q; Ren G; Xiang T
    Int J Oncol; 2018 Sep; 53(3):961-972. PubMed ID: 29956735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced serum methylated p16 DNAs is associated with the progression of gastric cancer.
    Wu YC; Lv P; Han J; Yu JL; Zhu X; Hong LL; Zhu WY; Yu QM; Wang XB; Li P; Ling ZQ
    Int J Clin Exp Pathol; 2014; 7(4):1553-62. PubMed ID: 24817951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Joint Effects Between CDKN2B/P15 Methylation and Environmental Factors on the Susceptibility to Gastric Cancer.
    Zhou H; Nie C; Tian W; Han X; Wang J; Du X; Wang Q; Zhu X; Xiang G; Zhao Y
    Dig Dis Sci; 2023 Jul; 68(7):3009-3017. PubMed ID: 36961670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New blood markers detection technology: A leap in the diagnosis of gastric cancer.
    Beeharry MK; Liu WT; Yan M; Zhu ZG
    World J Gastroenterol; 2016 Jan; 22(3):1202-12. PubMed ID: 26811658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methylation status of COX-2 in blood leukocyte DNA and risk of gastric cancer in a high-risk Chinese population.
    Su HJ; Zhang Y; Zhang L; Ma JL; Li JY; Pan KF; You WC
    BMC Cancer; 2015 Dec; 15():979. PubMed ID: 26674784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peripheral Blood-Based DNA Methylation of Long Non-Coding RNA H19 and Metastasis-Associated Lung Adenocarcinoma Transcript 1 Promoters are Potential Non-Invasive Biomarkers for Gastric Cancer Detection.
    Hu D; Lou X; Meng N; Li Z; Teng Y; Zou Y; Wang F
    Cancer Control; 2021; 28():10732748211043667. PubMed ID: 34615385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenetic inactivation of FAT4 contributes to gastric field cancerization.
    Yoshida S; Yamashita S; Niwa T; Mori A; Ito S; Ichinose M; Ushijima T
    Gastric Cancer; 2017 Jan; 20(1):136-145. PubMed ID: 26792292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between the methylation of the STAT1 and SOCS3 in peripheral blood and gastric cancer.
    Han Q; Zhou H; Xie W; Sun T; Wei R; Nie C; Hong J; Zhu L; Tian W
    J Gastroenterol Hepatol; 2020 Aug; 35(8):1347-1354. PubMed ID: 32108380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.